Weekly NIH Funding Opportunities and Notices for September 25, 2020

Policy Notices

• Changes to the HHS Notice of Award (NoA) Beginning October 1, 2020
  (NOT-HS-20-017)
  Agency for Healthcare Research and Quality

• Reminder: NIH Natural Disaster Policy Wildfires
  (NOT-OD-20-176)
  National Institutes of Health

General Notices

• Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-20-084)
  (NOT-EB-20-019)
  National Institute of Biomedical Imaging and Bioengineering

• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-001 "Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)"
  (NOT-HL-20-817)
  National Heart, Lung, and Blood Institute

• Notice of NIMHD Participation in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)"
  (NOT-MD-20-028)
  National Institute on Minority Health and Health Disparities

• Review of the Accuracy of Grants Information for Fiscal Year 2020
  (NOT-OD-20-175)
  National Institutes of Health

• Pre-Application Webinar for NCATS RFA-TR-20-031 and RFA-TR-20-032, Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases
  (NOT-TR-20-038)
  National Center for Advancing Translational Sciences

• Request for Information (RFI): Pediatric preclinical models (cell lines and patient-derived xenografts) for which genomic characterization will enhance research value
  (NOT-CA-20-108)
  National Cancer Institute

Notice of Changes to Funding Opportunities

• Notice of Correction for RFA-AA-20-009 "Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)"
  (NOT-AA-20-021)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Change in Application Types Allowed for PAR-19-070 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
  (NOT-AG-20-052)
  National Institute on Aging

• Notice of NIAID's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
  (NOT-AI-20-074)
  National Institute of Allergy and Infectious Diseases

• Notice of NIAID's Participation in PAR-19-342: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 Clinical Trial Not Allowed)
  (NOT-AI-20-075)
  National Institute of Allergy and Infectious Diseases

• Notice of FY2021 Cohort Dates for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
  (NOT-CA-20-106)
  National Cancer Institute

• Notice of Correction to PAR-20-295 Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection In Vivo (R01 Clinical Trials optional)
  (NOT-CA-20-107)
  National Cancer Institute

• Notice of Change to RFA-OD-20-016, "Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)"
  (NOT-DA-20-081)
  National Institute on Drug Abuse

• Notice of Change to NIEHS target FOAs for NOT-HL-20-788 "Notice of Special Interest (NOSI): Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations"
  (NOT-HL-20-015)
  National Heart, Lung, and Blood Institute
  National Institute of Environmental Health Sciences

• Notice of NHLBI Participation in RFA-OD-19-029: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
  (NOT-HL-20-812)
  National Heart, Lung, and Blood Institute

• Notice of Correction to Application Submission Information for NOT-MD-20-025 "Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities"
  (NOT-MD-20-030)
  National Institute on Minority Health and Health Disparities

• Notice of Change to Key Dates for RFA-NS-19-002 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)
  (NOT-NS-21-002)
  National Institute of Neurological Disorders and Stroke

• Notice of Change to Key Dates for RFA-NS-19-003 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
  (NOT-NS-21-003)
  National Institute of Neurological Disorders and Stroke

• Notice of Change to Key Dates for RFA-NS-19-001 "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)"
  (NOT-NS-21-009)
  National Institute of Neurological Disorders and Stroke

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician-Scientist Award in Alzheimers Disease and its Related Dementias (AD/ADRD)
  (NOT-AG-20-043)
  National Institute on Aging

• Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
  (NOT-OD-21-001)
  National Institutes of Health
  National Center for Advancing Translational Sciences

Funding Opportunities

• State Occupational Safety and Health Surveillance Program (U60)
  (PAR-20-312)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): December 16, 2020; September 14, 2021; September 14, 2022 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time on the listed application due date. Applicant organizations are strongly encouraged to start the registration process at least 4 weeks prior to the application due date Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window)
• Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed)
  (RFA-AI-20-055)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 11, 2021
• Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
  (RFA-CA-20-046)
  National Cancer Institute
  Application Receipt Date(s): December 15, 2020; December 14, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed)
  (RFA-DC-20-002)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): October 23, 2020; June 10, 2021; February 10, 2022; October 11, 2022; June 13, 2023 apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional)
  (RFA-DK-20-504)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 16, 2020
• Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional)
  (RFA-DK-20-505)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 16, 2020
• Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed)
  (RFA-DK-20-509)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 9, 2021
• Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed)
  (RFA-ES-20-007)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): January 15, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed)
  (RFA-HL-21-018)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): See full announcement for details
• BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
  (RFA-MH-20-620)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): December 9, 2020; August 10, 2021, April 11, 2022, December 9, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-MH-20-701)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed)
  (RFA-MH-20-702)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.

Michael J. Karcher, Ed.D., Ph.D.
Associate Dean for Research

Professor of Educational Psychology

College of Education and Human Development (COEHD)—UTSA
501 Cesar Chavez Blvd., Suite DB 4.337 (DT); MB 3.476 (Main Campus) 
(210) 458-2032; 458-2650 (department)
michael.karcher@utsa.edu

Emily P. Bonner, Ph.D.

Assistant Dean for Research

Associate Professor, C&I

Co-Director, San Antonio Mathematics Collaborative

Chair, UTSA Faculty Senate

College of Education and Human Development (COEHD)—UTSA

(210) 458-5402

emily.bonner@utsa.edu

Raitza Garcia

Assistant Director of Development

College of Education and Human Development

The University of Texas at San Antonio

Mail: One UTSA Circle, San Antonio, TX  78249

Office: MB 3.488

Office: 210-458-6505 (Mobile: 210-831-4609)

Iwan Notowidigdo

Senior Grant Development Coord.

(Mobile: 347-231-5931)

iwan.notowidigdo@gmail.com

iwan.notowidigdo@utsa.edu